No Data
No Data
Nevro Corp Announced The Publication Of New Data In The Journal Of Pain Research With Encouraging Results Regarding Pain Relief And Long Term Meaningful Reductions in A1C
New Data Demonstrates Long-Term Improvements in Pain Intensity With Nevro's High-Frequency Spinal Cord Stimulation Therapy
Press Release: Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Mizuho Securities Maintains Nevro(NVRO.US) With Hold Rating, Cuts Target Price to $8
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024
RBC Capital Maintains Nevro(NVRO.US) With Hold Rating, Maintains Target Price $7
No Data
No Data